Bristol’s Growth Plans Take A Hit As Cobenfy Fails As A Schizophrenia Add-On

Setback Follows Camzyos Stumble In nHCM

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.